PDCD1 and classic Hodgkin lymphoma: However, the fact that relapse has not occurred in this patient, four years after stopping pembrolizumab, even after the immunological stress of pregnancy, evokes the possibility that similarly to BV,23 a proportion of patients with relapsed cHL may be cured with PD1 inhibitors.